IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,235 | -9.5% | 627 | 0.0% | 0.00% | – |
| Q2 2023 | $5,787 | -32.8% | 627 | 0.0% | 0.00% | – |
| Q1 2023 | $8,615 | -42.9% | 627 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $15,079 | +7.7% | 627 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | +27.3% | 627 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -35.3% | 627 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $17,000 | -5.6% | 627 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | -56.1% | 627 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $41,000 | -21.2% | 627 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $52,000 | +8.3% | 627 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $48,000 | -12.7% | 627 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $55,000 | +19.6% | 627 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $46,000 | 0.0% | 627 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $46,000 | +91.7% | 627 | +47.2% | 0.00% | +100.0% |
| Q1 2020 | $24,000 | +50.0% | 426 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | – | 426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |